Institut de Myologie, France
33
5
5
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 33 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
5%
1 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (33)
Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
Role: lead
Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders
Role: lead
Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders
Role: lead
Longitudinal Evaluation of Neuromuscular Involvement in Type 1 Myotonic Dystrophy
Role: lead
Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis
Role: collaborator
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Role: lead
Study of the Reproducibility of the French Version of the Modified SMAFRS Scale
Role: lead
Natural History Study of Children With LAMA2-related Dystrophies
Role: lead
French Observatory for Patients with Type 3 Glycogenosis
Role: lead
Sensitivity and Reproducibility of 18F-fluorodeoxyglucose Positron Emission Tomography for Assessment of Respiratory Muscle Activity
Role: lead
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study
Role: lead
Virtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1
Role: lead
Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient Mobility in Daily Living
Role: lead
Ultrafast Ultrasound for the Functional Assessment of the Diaphragm
Role: lead
Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies
Role: lead
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
Role: lead
European Registry of Patients With Infantile-onset Spinal Muscular Atrophy
Role: lead
Phase I/II Study of SRP-4053 in DMD Patients
Role: collaborator
Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)
Role: lead
Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy
Role: lead